Schedule I Controlled Substance

How to Study Schedule I Controlled Substances

Q:  I want to study schedule I controlled substances. I want to study marijuana (cannabis), peyote, MDMA, psilocybin, LSD, ayahuasca/DMT and ibogaine, to start. A:  All of that is possible, but you should choose just one. Q:  OK, I want to study cannabis. A:  That’s actually one of the hardest. Please choose a better one.

Ketamine Drug chemistry structure

Ketamine Clinics and the DEA

Recently, we’ve been writing about ketamine-infusion clinics, which are increasingly popping up across the country (see a list of our past coverage at the end of this post). Over the coming weeks, we’ll dive deeper into individual laws and regulations governing clinics. Today, we focus on some of the high-level requirements of the Drug Enforcement

ketamine chemistry structure drawn on chalk board

Ketamine Clinics and the Corporate Practice of Medicine in California

Ketamine clinics are increasing in number in the United States and globally. As we described previously, ketamine is a Schedule III drug under the federal Controlled Substances Act, has been approved by the Food and Drug Administration (FDA) for certain medical uses, and may in some cases be used for off-label uses (such as anxiety

Psychoactive dry magic mushrooms.

Oregon Psychedelics: Petition to Legalize Psilocybin for Therapy Moves Forward

Last Friday, May 22, petitioners submitted to the Oregon Secretary of State a ballot initiative (IP 34) seeking to permit the use of psilocybin for therapeutic use under a licensing and regulatory framework administered by the Oregon Health Authority (“OHA”). The submission was quite a feat, especially given the challenges presented by COVID-19 during the

psychedelics law blog psilocybin prescription

Will Psilocybin Clinics Be The Next Big Thing in Treating Depression?

Earlier this year we wrote about the movement to decriminalize psilocybin – noting its success in Denver, Oakland, and Santa Cruz – and that nearly 100 other cities are looking at decriminalizing psychedelics. (The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)). That article posited that psilocybin would move along two tracks

ketamine chemical formula

The Ketamine Clinic Craze: Legalities and Possibilities

In recent years, the United States has seen a proliferation of ketamine clinics. From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. In an even larger trend, the health care provider

The Effort to Decriminalize Psilocybin in California is Underway

The Effort to Decriminalize Psilocybin in California is Underway

Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver, and Santa Cruz have decriminalized psilocybin to varying degrees. Much like cannabis, public perception of certain psychedelics like psilocybin is shifting rapidly, as people really the incredible

Cannabis and Psychedelics

The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)

There is a bona fide movement underway with psilocybin. Decriminalization occurred last year in Denver, Oakland and Santa Cruz, and that was just a start: nearly 100 other cities are looking at decriminalizing psychedelics. At the state level, ballot measures are out for signature in California and Oregon. Federally, legislation has been proposed to allow

PSILOCYBIN trademark

USPTO Grants Trademark for PSILOCYBIN, But Don’t Get Too Worked Up Yet

A few weeks back, Twitter was abuzz about the fact that the United State Patent and Trademark Office (“USPTO”) granted a federal trademark registration for the word PSILOCYBIN. The mark was registered by the company Black Pandas LLC and applies to the following services in Class 041: “Development and dissemination of education materials of others